FindTrial
Sign In

Observational study of findings in inner most layer called retina and middle layer choroid in eyes with patients Vogt Koyanagi Harada Syndrome in a scan called Spectral Domain Optical Coherence Tomography

Retinal and Choroidal Spectral Domain Optical Coherence Tomography Findings in Vogt Koyanagi Harada Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/11/021982
Enrollment
34
Registered
2019-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H208- Other iridocyclitis

Interventions

None listed

Sponsors

Dr Sushad Prasad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients satisfying diagnostic criteria of Vogt Koyanagi Harada syndrome at any stages of the diseases. 2) All patients with Vogt Koyanagi Harada syndrome aged more than or equal to 10 years in whom and Fundus Fluorescein Angiography is feasible.

Exclusion criteria

Exclusion criteria: 1) Patients with the history of ocular surgeries. 2) Patients with the history of ocular trauma. 3) Individuals with significant media opacities and other intaocular media pathologies. 4) Patients with primary retinal diseases.

Design outcomes

Primary

MeasureTime frame
Measurement of following parameters in eyes with Vogt Koyanagi Harada syndrome in Spectral Domain Optcal Coherence Tomography at various phases of disease: i) The Inner Retinal Thickness on Spectral Domain-Optical Coherence Tomography. ii) Sub retinal fluid (SRF) on Spectral Domain-Optical Coherence Tomography. iii) Height of Retinal detachment. iv) Choroidal thickness v) RPE undulation index. Timepoint: Outcomes are measured at the first visit of patients to the hospital. No further followup will be taken for study.—

Secondary

MeasureTime frame
Following parameters in Spectral Domain Optical Coherence Tomography in eyes with Vogt Koyanagi Harada syndrome are observed 1)Internal limiting membrane folds 2)Retinal pigment epithelium folds 3)Cyst in outer retinal layers 4)IS-OS disruption 5)Pigment Epithelial Detachment Timepoint: These outcomes are observed at the time of first visit of patient to the hospital. No further follow up is taken into the study—

Countries

India

Contacts

Public ContactDr Sushad Prasad

Aravind Eye Hospital and Postgraduate Institute of Ophthalmology

drbalamuruganms@gmail.com9360384382

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026